Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.

Abstract

INTRODUCTION Chemotherapy-induced nausea and vomiting (CINV) has been shown to adversely impact patient anxiety, quality of life, treatment adherence, and use of health care resources. CINV control still remains a challenge, and lack of effective communication between the patient and clinician has been highlighted in the literature as the main barrier to… (More)
DOI: 10.1177/1078155214540317

Topics

Cite this paper

@article{Warr2015FeasibilityOU, title={Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.}, author={Julia K Warr and Carole R Chambers and Frances L Cusano and C A Cuthbert and Michelle S Mah}, journal={Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners}, year={2015}, volume={21 5}, pages={348-57} }